Patent US1690654A successfully refreshed from Google Patents.
Patent US6016452A successfully refreshed from Google Patents.
← Back to Patent Explorer
US6016452A Expired / Lapsed US ⏱️ 0.0 years remaining

Dynamic heating method and radio frequency thermal treatment

Assignee: Individual
•
Filing: 1997-03-19
•
Granted: 2000-01-18
•
Expires: 2017-03-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method and system for the delivery of radiofrequency energy to the tissue, particularly, the prostate, to alleviate the symptoms of BPH is disclosed. The system incorporates a bipolar or multipolar electrode array to create an electric field where the heat created is confined solely to a specific volume of the prostate gland and therefore the heated tissue is defined only by the electrode geometry. The bipolar electrode array provides a variety of three dimensional, symmetric heating patterns within the prostatic tissue depending on the relative electrode lengths and angular separation. The system provides precision tissue temperature and impedance measurements thereby enabling the surgeon to accurately predict heating pattern performance and tissue response to RF heating.

Inventors

  • 👤 Raymond S. Kasevich

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:16
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/04; A61B18/12; A61B18/14; A61B18/1477; A61B18/1206; A61N; A61N1/00; A61N1/40; A61N1/403; A61B18/18; A61B18/1815; A61B2018/00315; A61B2018/00547; A61B2018/00571; A61B2018/00577; A61B2018/00595; A61B2018/00625; A61B2018/00636; A61B2018/00696; A61B2018/00702; A61B2018/00773; A61B2018/00779; A61B2018/00785; A61B2018/00791; A61B2018/00875

Claims Analysis

Total Claims: 24
Claim 1
Independent Claim 182 words
A system for the radiofrequency hyperthermia treatment of prostatic tissue, which comprises: a transurethral applicator including: a housing; an elongated portion extending from the housing and dimensioned to be introduced within the urethral passage of a patient; at least three radiofrequency bipolar electrodes supported within the elongated portion and being deployable to penetrate a urethra wall defining the urethral passage and enter prostatic tissue to define a predetermined electrode arrangement therein; a deployment mechanism associated with the housing for deploying the at least three bipolar electrodes, the deployment mechanism including a first actuator connected to a first bipolar electrode and selectively movable to selectively deploy the first bipolar electrode and a second actuator connected to a second and a third bipolar electrode and selectively movable to selectively deploy the second and the third bipolar electrodes to control positioning of the second and third bipolar electrode relative to the first bipolar electrode; and a radiofrequency source connected to the three bipolar electrodes for supplying radiofrequency energy such that the predetermined electrode arrangement generates a three dimensional thermal energy pattern within the prostatic tissue.
Claim 2
Independent Claim 182 words
A system for the radiofrequency hyperthermia treatment of prostatic tissue, which comprises: a transurethral applicator including: a housing; an elongated portion extending from the housing and dimensioned to be introduced within the urethral passage of a patient; at least three radiofrequency bipolar electrodes supported within the elongated portion and being deployable to penetrate a urethra wall defining the urethral passage and enter prostatic tissue to define a predetermined electrode arrangement therein; a deployment mechanism associated with the housing for deploying the at least three bipolar electrodes, the deployment mechanism including a first actuator connected to a first bipolar electrode and selectively movable to selectively deploy the first bipolar electrode and a second actuator connected to a second and a third bipolar electrode and selectively movable to selectively deploy the second and the third bipolar electrodes to control positioning of the second and third bipolar electrode relative to the first bipolar electrode; and a radiofrequency source connected to the three bipolar electrodes for supplying radiofrequency energy such that the predetermined electrode arrangement generates a three dimensional thermal energy pattern within the prostatic tissue.
Claim 3
Dependent Claim 38 words
The system according to claim 1 wherein the deployment mechanism is adapted to deploy the bipolar electrodes to define a predetermined electrode arrangement wherein the second and third bipolar electrodes are symmetrically arranged about the first bipolar electrode.
Claim 4
Dependent Claim 52 words
The system according to claim 2, wherein the elongated portion of the applicator has a distal deployment tip portion associated therewith, the deployment tip portion defining deployment ports, configured and dimensioned to deploy the bipolar electrodes such that the first, second and third bipolar electrodes lie substantially within the same general plane.
Claim 5
Dependent Claim 42 words
The system of claim 1, further including means for initially supplying said radiofrequency (RF) energy at frequency of less than one MHZ and then supplying said RF energy at a frequency in the range of about 13-40 MHz to ablate target tissue.
Claim 6
Dependent Claim 22 words
The system of claim 1, wherein said electrodes are provided with a lossy dielectric coating to influence current flow on the electrodes.
Claim 7
Dependent Claim 32 words
The system according to claim 1 including a temperature sensor associated with a distal end portion of the elongated portion to monitor the temperature of the tissue adjacent the distal end portion.
Claim 8
Dependent Claim 39 words
The system of claim 1, further including a balun for transforming impedance between a coaxial cable that supplies RF energy from said RF source, and impedance measurement circuitry coupled to said coaxial cable for measuring impedance of treatment tissue.
Claim 9
Dependent Claim 179 words
The system according to claim 1, further including a control unit having a coaxial output providing RF energy to said electrodes, and a balun interconnecting said electrodes with said coaxial output, said control unit comprising: a processor system that monitors impedance of tissue in the area being treated; a directional coupler coupled between said radiofrequency source and said coaxial output for providing forward and reverse power to an interface that provides impedance information to said processor system; at least one switch for switching the output of said directional coupler between a first electrical path terminating in a short circuit, a second electrical path terminating in a test load, and a third electrical path terminating in an open circuit, to enable an impedance calibration to be performed; and said at least one switch being further capable of switching said directional coupler output to a fourth electrical path including said coaxial output and said balun, to provide RF energy to said electrodes and to enable said directional coupler to couple reverse power during treatment towards said interface for calibrated impedance monitoring.
Claim 10
Dependent Claim 12 words
The system of claim 8, wherein said interface comprises a vector analyzer.
Claim 11
Dependent Claim 12 words
The system of claim 9, wherein said interface comprises a network analyzer.
Claim 12
Dependent Claim 25 words
The system of claim 8, further including a temperature sensor for monitoring temperature at the test load and providing corresponding information to said processor system.
Claim 13
Dependent Claim 21 words
The system of claim 8, wherein said radiofrequency source provides RF energy at a frequency of about 40 MHZ or less.
Claim 14
Dependent Claim 27 words
The system of claim 8, further comprising a detector for detecting an output signal level at said test load and providing corresponding information to said processor system.
Claim 15
Independent Claim 170 words
An apparatus for treating prostatic tissue comprising: a) a handle assembly; b) an elongate body extending distally from the handle assembly and having an axial bore extending at least partially therethrough defining a longitudinal axis; c) first, second, and third elongated probes supported within the elongate body and mounted for movement between respective retracted positions disposed within the axial bore and respective deployed positions projecting outwardly from a distal end portion of the elongate body; d) a first actuator associated with the handle assembly and operatively connected to the first probe for selectively moving the first probe between the retracted and deployed positions thereof independent of the second and third probes; e) a second actuator associated with the handle assembly and operatively connected to the second and third probes for selectively and conjunctively moving the second and third probes between the retracted and deployed positions thereof independent of the first probe; and f) means for operatively connecting the first, second and third probes to an external source of radiofrequency energy.
Claim 16
Independent Claim 170 words
An apparatus for treating prostatic tissue comprising: a) a handle assembly; b) an elongate body extending distally from the handle assembly and having an axial bore extending at least partially therethrough defining a longitudinal axis; c) first, second, and third elongated probes supported within the elongate body and mounted for movement between respective retracted positions disposed within the axial bore and respective deployed positions projecting outwardly from a distal end portion of the elongate body; d) a first actuator associated with the handle assembly and operatively connected to the first probe for selectively moving the first probe between the retracted and deployed positions thereof independent of the second and third probes; e) a second actuator associated with the handle assembly and operatively connected to the second and third probes for selectively and conjunctively moving the second and third probes between the retracted and deployed positions thereof independent of the first probe; and f) means for operatively connecting the first, second and third probes to an external source of radiofrequency energy.
Claim 17
Dependent Claim 48 words
An apparatus as recited in claim 14, wherein first, second and third guide channels are defined in a distal end portion of the elongated body in communication with the axial bore thereof for respectively directing the first second and third probes outwardly toward the respective deployed positions thereof.
Claim 18
Dependent Claim 21 words
An apparatus as recited in claim 14, wherein the first, second and third probes are each configured as a bipolar electrode.
Claim 19
Dependent Claim 37 words
An apparatus as recited in claim 16, wherein each probe defines a distal radiating segment and wherein upon deployment of the first, second and third probes the distal radiating segments are oriented within the same geometric plane.
Claim 20
Independent Claim 107 words
A method for the hyperthermia treatment of prostatic tissue, comprising the steps of: inserting a transurethral applicator within the urethral passage of a patient, the applicator including at least first, second and third radiofrequency bipolar electrodes supported therein; deploying the bipolar electrodes from the applicator whereby the bipolar electrodes penetrate the urethral wall and enter prostatic tissue to define a predetermined electrode arrangement of the bipolar electrodes within the prostatic tissue, the second and third bipolar electrodes being deployed independent of the first bipolar electrode; supplying radiofrequency energy to the electrode arrangement whereby the electrode arrangement generates a three dimensional thermal energy pattern within the prostatic tissue.
Claim 21
Independent Claim 107 words
A method for the hyperthermia treatment of prostatic tissue, comprising the steps of: inserting a transurethral applicator within the urethral passage of a patient, the applicator including at least first, second and third radiofrequency bipolar electrodes supported therein; deploying the bipolar electrodes from the applicator whereby the bipolar electrodes penetrate the urethral wall and enter prostatic tissue to define a predetermined electrode arrangement of the bipolar electrodes within the prostatic tissue, the second and third bipolar electrodes being deployed independent of the first bipolar electrode; supplying radiofrequency energy to the electrode arrangement whereby the electrode arrangement generates a three dimensional thermal energy pattern within the prostatic tissue.
Claim 22
Dependent Claim 50 words
the method according to claim 18, wherein the step of deploying includes deploying the three bipolar electrodes from the applicator to define a predetermined electrode arrangement characterized by having a first centrally disposed bipolar electrode and second and third bipolar electrodes symmetrically arranged about the first centrally disposed bipolar electrode.
Claim 23
Dependent Claim 32 words
The method according to claim 19, wherein the step of deploying includes deploying the three bipolar electrodes such that the first, second and third bipolar electrodes generally lie within the same place.
Claim 24
Dependent Claim 40 words
The method according to claim 20, wherein the step of deploying includes deploying the three bipolar electrodes such that the second and third bipolar electrodes define an angle ranging from about 5° to 85° relative to the first bipolar electrode.

References Cited (Backward Citations)

US32057A Cited
US32066A Cited
US3991770A Cited
US4011872A Cited
USRE32057E Cited
USRE32066E Cited
US4121592A Cited
US4154246A Cited
US4237898A Cited
US4311154A Cited
US4448198A Cited
US4280503A Cited
US4565200A Cited
US4411266A Cited
US4805616A Cited
US4423727A Cited
US4503855A Cited
GB2119253A Cited
US4676258A Cited
US4601296A Cited
US4763671A Cited
US4798215A Cited
US4658836A Cited
US4823791A Cited
US4950267A Cited
US4907589A Cited
US4917082A Cited
US5249585A Cited
US5220927A Cited
US4896671A Cited
US4920978A Cited
US5159925A Cited
US5151100A Cited
US5368591A Cited
US4955377A Cited
US5191883A Cited
JPH02121675A Cited
US4966597A Cited
US5509929A Cited
US5246438A Cited
US5098431A Cited
US4979948A Cited
US5057107A Cited
US5084044A Cited
US5007908A Cited
US5078716A Cited
US5186181A Cited
US5083565A Cited
US5282799A Cited
US5301687A Cited
US5383917A Cited
US5273524A Cited
US5423808A Cited
US5290286A Cited
US5192280A Cited
US5197963A Cited
US5304214A Cited
US5295955A Cited
US5330518A Cited
US5464445A Cited
US5413588A Cited
US5540681A Cited
US5401274A Cited
US5300068A Cited
US5318563A Cited
US5341807A Cited
US5531676A Cited
US5470308A Cited
US5599294A Cited
US5542916A Cited
US5409453A Cited
US5542915A Cited
US5421819A Cited
US5370675A Cited
US5540655A Cited
US5435805A Cited
US5536240A Cited
US5531677A Cited
US5484400A Cited
US5385544A Cited
US5470309A Cited
US5342357A Cited
US5383876A Cited
US5334193A Cited
US5437662A Cited
US5545161A Cited
EP0608609A2 Cited
US5409006A Cited
US5486161A Cited
US5403311A Cited
US5364392A Cited
US5464437A Cited
US5431649A Cited
US5472441A Cited
US5458597A Cited
US5599345A Cited
US5599346A Cited
US5507743A Cited
US5441498A Cited
US5454782A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-01-17 2003-07-19 2004-01-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-01-17 2007-07-19 2008-01-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-01-17 2011-07-19 2012-01-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag